2024-02-27 05:54:31 Roche Korea (CEO Nick Horridge) announced on February 27 that its influenza treatment drug, Xofluza (ingredient name: baloxavirmarboxil), was used for the treatment and exposure of influenza type A or B virus infection in children over 1 year of age. It was announced that a new suspension formulation has been launched as a … Read more
You can read the full story here: Xofluza: New Influenza Treatment for Children Over 1 Year Old by Roche Korea.
technology today: 2024-05-06 00:03:00
May 6, 2024
No Comments